Celcuity (CELC) Tops Q3 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
Go back to Celcuity (CELC) Tops Q3 EPS by 1c
November 7, 2019 4:01 PM EST
MINNEAPOLIS--(BUSINESS WIRE)--
Celcuity Inc. (Nasdaq: CELC), a functional cellular analysis company that is discovering new cancer subtypes and commercializing diagnostic tests designed to significantly improve clinical outcomes of cancer patients treated with targeted therapies, announced financial results for the third quarter ended September 30, 2019.
Unless otherwise stated, all comparisons are for the third quarter ended September 30, 2019, compared to the third quarter ended September 30, 2018.
Celcuity reported a net loss of $1.98 million, or $0.19 per share, for the third quarter of 2019, compared to a net loss of $1.87 million, or $0.18 per share, for... More
